Michael Kauffman

Michael Kauffman

About

Detail

Cofounder
North Miami Beach, Florida, United States

Timeline


work
Job
school
Education

Résumé


Jobs verified_user 0% verified
  • Verastem Oncology
    President of Development; Board Member
    Verastem Oncology
    Dec 2025 - Current (7 months)
  • FibroGen Inc
    Board Member
    FibroGen Inc
    Jun 2025 - Current (1 year 1 month)
  • FoRx Therapeutics
    Chairman of the Board
    FoRx Therapeutics
    May 2024 - Current (2 years 2 months)
  • Nereid Therapeutics
    CEO and President
    Nereid Therapeutics
    Nov 2023 - Jun 2025 (1 year 8 months)
  • I
    Chairperson of the Board
    Incendia Therapeutics
    Oct 2022 - Current (3 years 9 months)
  • S
    Senior Clinical Advisor
    SIRTLab Corporation
    Jun 2022 - Jul 2023 (1 year 2 months)
    SIRTLab Corporation is focused on the treatment of severe Non-Alcoholic Steatohepatitis (NAXH), other Severe Liver Diseases and Longevity based on Sirtuin 6 (SIRT6) modulation.
  • BiVictriX Therapeutics Ltd
    Chairperson of the Board
    BiVictriX Therapeutics Ltd
    Jan 2022 - Current (4 years 6 months)
  • Adicet Bio Inc
    Board Member
    Adicet Bio Inc
    Jan 2022 - Aug 2024 (2 years 8 months)
  • Karyopharm Therapeutics Inc
    Cofounder
    Karyopharm Therapeutics Inc
    May 2021 - Current (5 years 2 months)
  • Karyopharm Therapeutics Inc
    Senior Clinical Advisor
    Karyopharm Therapeutics Inc
    May 2021 - May 2022 (1 year 1 month)
  • Kezar Life Sciences
    Board Member
    Kezar Life Sciences
    Jan 2017 - Current (9 years 6 months)
  • Karyopharm Therapeutics Inc
    CEO
    Karyopharm Therapeutics Inc
    Jan 2011 - May 2021 (10 years 5 months)
    Discovery, development, approval and commercialization of XPOVIO® (NEXPOVIO®) for multiple myeloma and lymphoma. Additional novel drugs targeting the nuclear pore complex for cancer, inflammation, viral diseases, and other disorders of proliferation.
  • Verastem Oncology
    Lead Director, Board Member
    Verastem Oncology
    Jan 2010 - Dec 2025 (16 years)
  • Onyx Pharmaceuticals Inc an Amgen subsidiary
    Chief Medical Officer
    Onyx Pharmaceuticals Inc an Amgen subsidiary
    Nov 2009 - Dec 2010 (1 year 2 months)
  • Bessemer Venture Partners
    Operating Partner
    Bessemer Venture Partners
    Jan 2009 - Dec 2010 (2 years)
  • P
    Chief Medical Officer
    Proteolix Pharmaceuticals Inc
    Dec 2008 - Oct 2009 (11 months)
  • E
    Chief Executive Officer
    EPIX Pharmaceuticals
    Aug 2006 - Aug 2008 (2 years 1 month)
  • Z
    Board Member
    Zalicus Inc
    May 2006 - Jul 2014 (8 years 3 months)
  • P
    Chief Executive Officer
    Predix Pharmaceuticals Inc
    Sep 2002 - Aug 2006 (4 years)
  • Massachusetts General Hospital
    Rheumatology Fellowship / Internal Medicine Practice
    Massachusetts General Hospital
    Jul 1994 - Sep 1995 (1 year 3 months)
    Internal Medicine Practice Rheumatology Fellowship
  • B
    Internal Medicine Residency
    BETH ISRAEL HOSPITAL
    Jul 1992 - Jun 1994 (2 years)
    Internal Medicine Residency Harvard Teaching Hospital
  • M
    VP Clinical
    Millennium bcp
  • M
    Board of Directors
    Metamark Genetics
Education verified_user 0% verified
  • Johns Hopkins School of Medicine
    MD, PhD, Molecular Biology, Biochemistry
    Johns Hopkins School of Medicine
    Jan 1985 - Dec 1992 (8 years)
  • The Johns Hopkins University School of Medicine
    MD, PhD, Molecular Biology, Biochemistry
    The Johns Hopkins University School of Medicine
    Jan 1985 - Jan 1992 (7 years 1 month)
  • Amherst College
    Biochemistry
    Amherst College
This is a community-created genome.